Rankings
▼
Calendar
TKNO FY 2021 Earnings — Alpha Teknova, Inc. Revenue & Financial Results | Market Cap Arena
TKNO
Alpha Teknova, Inc.
$133M
FY 2021 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$37M
+17.9% YoY
Gross Profit
$18M
47.8% margin
Operating Income
-$12M
-32.5% margin
Net Income
-$10M
-26.6% margin
EPS (Diluted)
$-0.35
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$29M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$167M
Total Liabilities
$23M
Stockholders' Equity
$143M
Cash & Equivalents
$88M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$37M
$31M
+17.9%
Gross Profit
$18M
$18M
-0.8%
Operating Income
-$12M
$5M
-357.5%
Net Income
-$10M
$4M
-374.6%
← Q4 2020
All Quarters
Q1 2021 →